Home - Solve ME/CFS Initiative
Solve M.E. is a non-profit org focused on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Long Covid and other post-infection diseases.| Solve ME/CFS Initiative
Solve M.E. is a non-profit org focused on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Long Covid and other post-infection diseases.| Solve ME/CFS Initiative
Read our summary of a study by Dr. Akiko Iwasaki and her team that distinguishes groups of people with ME/CFS based on blood-plasma and cerebrospinal fluid proteins.| Solve ME/CFS Initiative
Solve has selected Simmaron Research as the recipient of our latest ME/CFS Catalyst Award. The funds will be used to accelerate a low-dose rapamycin trial for ME/CFS, Long COVID, and other infection-associated chronic conditions (IACCs). The study advances an FDA-approved drug for reducing key symptoms of ME/CFS and Long Covid, repurposing rapamycin to reduce fatigue, orthostatic intolerance, post-exertional malaise, and sleep issues for a subset of people with ME/CFS.| Solve ME/CFS Initiative
